We are live on ! Find out more
YIH

Y-Intercept (HK) Portfolio holdings

AUM $5.05B
1-Year Est. Return 17.89%
This Fund
S&P 500
This Quarter Est. Return
-0.78%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
AUM
$550M
AUM Growth
+$157M
Cap. Flow
+$181M
Cap. Flow %
32.82%
Top 10 Hldgs %
9.69%
Holding
1,013
New
425
Increased
119
Reduced
70
Closed
399

Top Buys

Rank Stock Value
1
NKE icon
Nike
NKE
+$5.22M
2
A icon
Agilent Technologies
A
+$4.93M
3
MSFT icon
Microsoft
MSFT
+$4.87M
4
TRI icon
Thomson Reuters
TRI
+$4.55M
5
NEE icon
NextEra Energy
NEE
+$4.49M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$12.2M
2
MRNA icon
Moderna
MRNA
+$8.97M
3
AAPL icon
Apple
AAPL
+$5.54M
4
QCOM icon
Qualcomm
QCOM
+$4.48M
5
UNH icon
UnitedHealth
UNH
+$4.44M

Sector Composition

Rank Sector Weight
1 Technology 17%
2 Healthcare 13.82%
3 Consumer Discretionary 11.58%
4 Financials 11.56%
5 Industrials 10.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVB icon
401
AvalonBay Communities
AVB
$26.8B
$389K 0.07%
+1,756
New +$394K
BMO icon
402
Bank of Montreal
BMO
$125B
$389K 0.07%
3,901
-733
-16% -$73.8K
ON icon
403
ON Semiconductor
ON
$34.7B
$389K 0.07%
+8,509
New +$364K
MED icon
404
Medifast
MED
$110M
$388K 0.07%
2,013
+1,067
+113% +$262K
ALSN icon
405
Allison Transmission
ALSN
$10.1B
$386K 0.07%
+10,930
New +$417K
CZR icon
406
Caesars Entertainment
CZR
$6.1B
$386K 0.07%
3,434
-6,815
-66% -$666K
PRU icon
407
Prudential Financial
PRU
$42.3B
$386K 0.07%
+3,671
New +$378K
AFRM icon
408
Affirm
AFRM
$24.5B
$381K 0.07%
+3,196
New +$255K
NUS icon
409
Nu Skin
NUS
$250M
$380K 0.07%
+9,387
New +$475K
FATE icon
410
Fate Therapeutics
FATE
$283M
$378K 0.07%
6,376
+1,248
+24% +$97.9K
CAR icon
411
Avis
CAR
$5.78B
$375K 0.07%
+3,222
New +$284K
DINO icon
412
HF Sinclair
DINO
$16.4B
$372K 0.07%
+11,217
New +$341K
PBA icon
413
Pembina Pipeline
PBA
$29B
$372K 0.07%
+11,732
New +$370K
TIGR
414
UP Fintech Holding
TIGR
$877M
$372K 0.07%
+35,110
New +$551K
ABMD
415
DELISTED
Abiomed Inc
ABMD
$371K 0.07%
+1,141
New +$387K
OZK icon
416
Bank OZK
OZK
$5.5B
$370K 0.07%
+8,610
New +$359K
URI icon
417
United Rentals
URI
$70.2B
$370K 0.07%
+1,055
New +$354K
STN icon
418
Stantec
STN
$8.05B
$368K 0.07%
+7,832
New +$371K
QTWO icon
419
Q2 Holdings
QTWO
$3.64B
$362K 0.07%
+4,514
New +$414K
SEDG icon
420
SolarEdge
SEDG
$2.62B
$362K 0.07%
1,366
-2,849
-68% -$776K
WBA
421
DELISTED
Walgreens Boots Alliance
WBA
$362K 0.07%
+7,700
New +$371K
BOTZ icon
422
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.2B
$358K 0.07%
+9,777
New +$351K
NOV icon
423
NOV
NOV
$7.35B
$358K 0.07%
+27,298
New +$368K
ZLAB icon
424
Zai Lab
ZLAB
$2.1B
$357K 0.06%
+3,385
New +$486K
AAP icon
425
Advance Auto Parts
AAP
$3.48B
$356K 0.06%
+1,703
New +$355K

Similar funds

Y-Intercept (HK)'s Q3 2021 Portfolio in Review

As of Q3 2021, Y-Intercept (HK) held 1,013 positions worth $550M, up 40% from $393M the previous quarter. Its ten largest holdings account for 9.7% of the portfolio.

Y-Intercept (HK) deployed $181M of net new capital in Q3 2021, opening 425 new positions and adding to 119 existing holdings. Its largest new stake was Nike: 32,025 shares worth $4.65M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $5.54M trimmed.

  • Y-Intercept (HK)'s largest Q3 2021 buy was Nike: 32,025 shares worth $4.65M.
  • Y-Intercept (HK) added most to Microsoft in Q3 2021, an estimated $4.87M increase.
  • Y-Intercept (HK)'s biggest Q3 2021 reduction was Apple, cutting an estimated $5.54M.
  • Y-Intercept (HK) fully exited Linde in Q3 2021, selling an estimated $12.2M.
  • Y-Intercept (HK)'s ten largest holdings make up 9.7% of its $550M portfolio in Q3 2021.
  • Y-Intercept (HK) opened 425 new positions and closed 399 in Q3 2021.
  • Y-Intercept (HK)'s portfolio value rose 40% quarter-over-quarter to $550M.

Based on Y-Intercept (HK)'s 13F filing for Q3 2021, filed 15 Nov 2021.